NO20044463L - Forbedret modifisert-frigjoringspreparat - Google Patents

Forbedret modifisert-frigjoringspreparat

Info

Publication number
NO20044463L
NO20044463L NO20044463A NO20044463A NO20044463L NO 20044463 L NO20044463 L NO 20044463L NO 20044463 A NO20044463 A NO 20044463A NO 20044463 A NO20044463 A NO 20044463A NO 20044463 L NO20044463 L NO 20044463L
Authority
NO
Norway
Prior art keywords
active ingredient
modified release
release preparation
coating
amount
Prior art date
Application number
NO20044463A
Other languages
English (en)
Inventor
Stefan Lukas
David Hayes
Angelo Lepore
Eugene Anthony Quinn
Original Assignee
Faulding F H & Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Faulding F H & Co Ltd filed Critical Faulding F H & Co Ltd
Publication of NO20044463L publication Critical patent/NO20044463L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Preparat med modifisert frigjøring som har ett eller flere belagte kjerneelementer. Hvert kjerneelement inkluderer en aktiv ingrediens og har et belegg med modifisert frigjøring. Et stabiliserende belegg er tilveiebrakt mellom hvert kjerneelement og dets belegg med modifisert frigjøring slik at, ved in vitro-oppløsningstesting, er mengden av aktiv ingrediens som frigjøres ved ethvert tidspunkt på en postlagringsoppløsningsprofil innen 40 prosentpoeng av mengden av aktiv ingrediens som frigjøres ved ethvert tidspunkt på en pre-lagringsoppløsningsprofil. Det beskrives også en fremgangsmåte for å administrere en aktiv ingrediens som, ved administrering i en umiddelbar frigjøringsform, normalt forårsaker kvalme og gastrisk irritasjon, idet fremgangsmåten inkluderer å administrere et preparat med modifisert frigjøring som her beskrevet.
NO20044463A 2002-04-12 2004-10-20 Forbedret modifisert-frigjoringspreparat NO20044463L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPS1676A AUPS167602A0 (en) 2002-04-12 2002-04-12 An improved modified release preparation
PCT/AU2003/000434 WO2003086366A1 (en) 2002-04-12 2003-04-11 An improved modified release preparation

Publications (1)

Publication Number Publication Date
NO20044463L true NO20044463L (no) 2004-11-11

Family

ID=3835253

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044463A NO20044463L (no) 2002-04-12 2004-10-20 Forbedret modifisert-frigjoringspreparat

Country Status (7)

Country Link
EP (1) EP1513505A4 (no)
JP (1) JP2005528388A (no)
AU (1) AUPS167602A0 (no)
CA (1) CA2480783C (no)
NO (1) NO20044463L (no)
NZ (1) NZ535372A (no)
WO (1) WO2003086366A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1768668A2 (en) 2004-06-16 2007-04-04 Tap Pharmaceutical Products, Inc. Multiple ppi dosage form
PE20091620A1 (es) 2008-03-11 2009-11-12 Takeda Pharmaceutical Preparacion solida de desintegracion oral
AR083651A1 (es) 2010-10-21 2013-03-13 Galderma Sa Composiciones de brimonidina en gel y metodos de uso
RU2013123055A (ru) * 2010-10-21 2014-11-27 Галдерма С.А. Таблетка с длительным высвобождением и способ ее получения
US9119793B1 (en) 2011-06-28 2015-09-01 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for doxycycline
CN102579408B (zh) * 2012-03-19 2013-06-05 河南中帅医药科技发展有限公司 盐酸多西环素双释放制剂及其制备方法
US10842802B2 (en) 2013-03-15 2020-11-24 Medicis Pharmaceutical Corporation Controlled release pharmaceutical dosage forms

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837030A (en) * 1987-10-06 1989-06-06 American Cyanamid Company Novel controlled release formulations of tetracycline compounds
IL95423A (en) * 1989-09-21 1994-11-11 American Cyanamid Co Pulse system for delivery of minocycline once daily
US5188836A (en) * 1990-07-27 1993-02-23 Warner-Lambert Company Sustained release formulations
WO1994002140A1 (en) * 1992-07-17 1994-02-03 Astra Aktiebolag Pharmaceutical composition containing antiulcer agent
SI9700186B (sl) * 1997-07-14 2006-10-31 Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin
CA2478121A1 (en) * 2002-03-07 2003-09-18 Advancis Pharmaceutical Corporation Antibiotic composition

Also Published As

Publication number Publication date
AUPS167602A0 (en) 2002-05-16
NZ535372A (en) 2008-03-28
CA2480783A1 (en) 2003-10-23
EP1513505A4 (en) 2011-02-16
CA2480783C (en) 2010-01-19
JP2005528388A (ja) 2005-09-22
EP1513505A1 (en) 2005-03-16
WO2003086366A1 (en) 2003-10-23

Similar Documents

Publication Publication Date Title
CY1105120T1 (el) Η αντιμετωπιση αναπνευστικων νοσων
HUP0401714A2 (hu) Propiverin vagy gyógyászatilag elfogadható sóinak nyújtott hatóanyag-eladású, orális adagolási formái
NO20011721D0 (no) N-aralkylaminotetraliner som ligander for neuropeptid Y Y5 reseptor
NO20001417L (no) Farmasøytisk preparat omfattende klodronat som aktiv bestanddel samt silisifiert mikrokrystallinsk cellulose som eksipient
DK0841904T3 (da) Orale farmaceutiske præparater med forsinket frigivelse af reversible protonpumpeinhibitorer
DK1183014T3 (da) Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse
PT797991E (pt) Formulacao com libertacao prolongada contendo venlafaxina
BR0315296A (pt) Derivados do ciclohexanol espirocìclicos
NO20080827L (no) Faste doseringsformuleringer av narkotiske legemidler som har forbedret bukal adsorpsjon
TW200719915A (en) Flavoring of drug-containing chewing gums
ES2088312T3 (es) Formulacion de liberacion controlada que contiene tramadol.
RS50360B (sr) Farmaceutske formulacije derivata platine
NO20052239L (no) Fast preparat
AR021858A1 (es) Composicion de liberacion modificada de particulas multiples
ATE334663T1 (de) Arzneimittelzusammensetzung mit verzögerter wirkstoffabgabe
NO20050771L (no) Bicifadinformulering
NO20045385L (no) Farmasoytisk preparat inneholdende okskarbazepin med kontrollert frigivelse av aktivt stoff
UY25234A1 (es) Formulación de liberación prolongada de venlafaxina
NO20013060D0 (no) Kontrollert frigjörende farmasöytisk preparat med tilidinmesylat som virkestoff
DE60235648D1 (de) Pharmazeutische metformintablette mit verlängerter freisetzung
NO20044463L (no) Forbedret modifisert-frigjoringspreparat
CY1105168T1 (el) Διφασικη συνθεση με τραμαδολη
BRPI0414822A (pt) método de inibir a produção de lipoproteìna remanescente
NO996049D0 (no) Kontrollert-frigjøring farmasoeytisk preparat med ACE inhibitor som aktivt middel
DE60320039D1 (de) Tramadol-formulierungen mit verzögerter freisetzung und 24-stunden-wirksamkeit

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application